XLO

XLO

USD

Xilio Therapeutics Inc. Common Stock

$0.685+0.018 (2.728%)

リアルタイム価格

Healthcare
バイオテクノロジー
米国

価格チャート

Loading Chart...

主要指標

市場指標
企業ファンダメンタルズ
取引統計

市場指標

始値

$0.667

高値

$0.685

安値

$0.667

出来高

0.37M

企業ファンダメンタルズ

時価総額

35.5M

業種

バイオテクノロジー

United States

取引統計

平均出来高

1.25M

取引所

NMS

通貨

USD

52週レンジ

安値 $0.62現在値 $0.685高値 $1.7

関連ニュース

GlobeNewswire

Xilio Therapeutics Appoints Akintunde Bello, Ph.D., to its Board of Directors

WALTHAM, Mass., June 10, 2025 (GLOBE NEWSWIRE) -- Xilio Therapeutics, Inc. (NASDAQ:XLO), a clinical-stage biotechnology company discovering and developing tumor-activated immuno-oncology therapies for people living

もっと見る
Xilio Therapeutics Appoints Akintunde Bello, Ph.D., to its Board of Directors
GlobeNewswire

Xilio Therapeutics Announces Closing of $50.0 Million Public Offering

Total gross proceeds of up to $150.0 million before the end of 2026 if all Series B warrants and Series C warrants are exercised for cash Xilio may elect to cancel unexercised Series B or Series C warrants

もっと見る
Xilio Therapeutics Announces Closing of $50.0 Million Public Offering
GlobeNewswire

Xilio Therapeutics Announces Inducement Grants Under Nasdaq Listing Rule 5635(c)(4)

WALTHAM, Mass., June 03, 2025 (GLOBE NEWSWIRE) -- Xilio Therapeutics, Inc. (NASDAQ:XLO), a clinical-stage biotechnology company discovering and developing tumor-activated immuno-oncology therapies for people living

もっと見る
Xilio Therapeutics Announces Inducement Grants Under Nasdaq Listing Rule 5635(c)(4)
GlobeNewswire

Xilio Therapeutics Announces Pricing of $50.0 Million Public Offering

WALTHAM, Mass., June 02, 2025 (GLOBE NEWSWIRE) -- Xilio Therapeutics, Inc. (NASDAQ:XLO), a clinical-stage biotechnology company discovering and developing tumor-activated immuno-oncology therapies for people living

もっと見る
Xilio Therapeutics Announces Pricing of $50.0 Million Public Offering